Erratum: The Naturally Processed CD95L Elicits a c-Yes/Calcium/PI3K-Driven Cell Migration Pathway (PLoS Biol (2011) 9: 6 (e1001090) DOI: 10.1371/journal.pbio.1001090)

Abstract

The following changes have been made to correct errors in this article and Correction [1, 2]. Additionally, reuse of data from [1] in a later article [3] is acknowledged in the corrected figure legends. Figures and legends: • The following figures have been updated to correct inconsistencies in the labeling: Figs 3, 4, 5, 6, S2, S3, S6, S9 and S10. • The legends for Figs 1–6 and S1-S10 have been updated to describe the control conditions, clarify the meaning of labels, state that all PS120 cells are transfected with wild-type NHE1, and acknowledge the reuse of data in figures within this article [1] and in a later article from the same groups [3]. • The Untreated zVAD panel in the updated S9B Fig is a replacement, as the original panel was an accidental duplication of a panel in Fig 5D. • A pair of fluorescence and brightfield panels for H9 Control were removed from S2C Fig because they did not present the same field of view. • Images in the following figures have been replaced with unmodified versions, with no changes to contrast or brightness: Figs 4A (PS120CD95(?1–210) panels), S9A and S10. • Underlying image data for the western blot experiments in the following figures are provided in S1 File: Figs 2, 4, 5, S1, S5, and S8. The underlying blot for H9 cells in S1C Fig is no longer available. The Materials and Methods section is supplemented with the following information provided in S2 File: • Protocol for the generation of control and CD95-expressing PS120-NHE1 cells. • Protocol for the transfection of Lifeact-GFP, PHAkt-GFP and GFP-Orai1. • Protocol for the production of Ig-CD95. • Information regarding CEM and SKW6.4 cell lines. • Description of PLCg1-reconsistuted Jurkat cells. • Sequences for all shRNAs, including scrambled. • Suppliers for PI3K isoform selective inhibitors, zVAD.